The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular characterization of a gastric cancer transmitted from an organ donor to four transplant recipients.
 
Chloe Evelyn Atreya
Consulting or Advisory Role - Array BioPharma; Array BioPharma; Array BioPharma; Array BioPharma; Pionyr; Pionyr; Pionyr; Pionyr
Research Funding - Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Genentech (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Guardant Health; Guardant Health; Guardant Health; Guardant Health; Merck; Merck; Merck; Merck; Novartis; Novartis; Novartis; Novartis
Travel, Accommodations, Expenses - Roche; Roche; Roche; Roche
 
Meyeon Park
Employment - Merck (I); Merck (I); Merck (I); Merck (I)
Stock and Other Ownership Interests - Merck (I); Merck (I); Merck (I); Merck (I)
Consulting or Advisory Role - Otsuka; Otsuka; Otsuka; Otsuka
 
James P. Grenert
No Relationships to Disclose
 
Spencer Behr
Honoraria - GE Healthcare; GE Healthcare; GE Healthcare; GE Healthcare
Consulting or Advisory Role - GE Healthcare (Inst); GE Healthcare (Inst); GE Healthcare (Inst); GE Healthcare (Inst)
Research Funding - GE Healthcare; GE Healthcare; GE Healthcare; GE Healthcare
 
Amalia Gonzalez
No Relationships to Disclose
 
Jonathan Chou
Stock and Other Ownership Interests - Array BioPharma (I); Array BioPharma (I); Array BioPharma (I); Array BioPharma (I); Atara Biotherapeutics (I); Atara Biotherapeutics (I); Atara Biotherapeutics (I); Atara Biotherapeutics (I); Celgene (I); Celgene (I); Celgene (I); Celgene (I)
 
Samantha Maisel
No Relationships to Disclose
 
Terence W. Friedlander
Leadership - Med BioGene; Med BioGene; Med BioGene; Med BioGene
Honoraria - AstraZeneca/MedImmune; AstraZeneca/MedImmune; AstraZeneca/MedImmune; AstraZeneca/MedImmune; EMD Serono; EMD Serono; EMD Serono; EMD Serono
Consulting or Advisory Role - Abbvie; Abbvie; Abbvie; Abbvie; Abbvie; Abbvie; Abbvie; Abbvie; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Foundation Medicine; Foundation Medicine; Foundation Medicine; Foundation Medicine; Janssen; Janssen; Janssen; Janssen; Pfizer; Pfizer; Pfizer; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); Janssen; Janssen; Janssen; Janssen; Seagen (Inst); Seagen (Inst); Seagen (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; AstraZeneca/MedImmune; AstraZeneca/MedImmune; AstraZeneca/MedImmune; Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche; Jounce Therapeutics; Jounce Therapeutics; Jounce Therapeutics; Jounce Therapeutics
 
Chris E. Freise
No Relationships to Disclose
 
Jun Shoji
No Relationships to Disclose
 
Thomas John Semrad
Consulting or Advisory Role - Celgene; Celgene; Celgene; Celgene; Genentech; Genentech; Genentech; Genentech
 
Peter Chin-Hong
No Relationships to Disclose
 
Eric A. Collisson
Stock and Other Ownership Interests - BloodQ; BloodQ; BloodQ; BloodQ; Clara Health; Clara Health; Clara Health; Clara Health; Gilead Sciences; Gilead Sciences; Gilead Sciences; Gilead Sciences; Guardant Health; Guardant Health; Guardant Health; Guardant Health; Hint Health; Hint Health; Hint Health; Hint Health; Illumina; Illumina; Illumina; Illumina; Tatara Therapeutics; Tatara Therapeutics; Tatara Therapeutics; Tatara Therapeutics
Consulting or Advisory Role - Guardant Health; Guardant Health; Guardant Health; Guardant Health; Takeda; Takeda; Takeda; Takeda
Research Funding - Ferro Oncology/Bridge Bio (Inst); Ferro Oncology/Bridge Bio (Inst); Ferro Oncology/Bridge Bio (Inst); Ferro Oncology/Bridge Bio (Inst); Ignyta (Inst); Ignyta (Inst); Ignyta (Inst); Ignyta (Inst); Loxo/Bayer (Inst); Loxo/Bayer (Inst); Loxo/Bayer (Inst); Loxo/Bayer (Inst); Merck KGaA (Inst); Merck KGaA (Inst); Merck KGaA (Inst); Merck KGaA (Inst); Senti Biosciences (Inst); Senti Biosciences (Inst); Senti Biosciences (Inst); Senti Biosciences (Inst)
 
Jessica Van Ziffle
No Relationships to Disclose